Drug ID: | NPD3949 |
Drug Name: | |
Molecular Formula: | C20H22N2O5 |
Canonical SMILES: | OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC |
Standard InCHI: | InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24) |
Standard InCHIKey: | NETXMUIMUZJUTB-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL001716 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 24871506 |
ChEBI | |
CAS Number |
Molecular Weight | 370.15 |
ALogP | -0.6571 |
MLogP | 2.89 |
XLogP | 2.235 |
HDA | 4 |
HBD | 2 |
Rotatable Bonds | 11 |
TPSA | 89.38 |
RO5 Violation | 0 |